Apimeds Pharmaceuticals US, Inc. 8-K/A

AMENDMENT NO. 1 TO FORM 8-K

AGREEMENT AND PLAN OF MERGER, DATED DECEMBER 1, 2025, BY AND BETWEEN APIMEDS PHARMACEUTICALS US, INC., APIMEDS MERGER SUB, INC., MINDWAVE INNOVATIONS INC, LOKAHI THERAPEUTICS, INC, AND ERIK EMERSON

CERTIFICATE OF CORRECTION TO CERTIFICATE OF DESIGNATION OF SERIES A CONVERTIBLE PREFERRED STOCK, AS FILED WITH THE DELAWARE SECRETARY OF STATE ON DECEMBER 10, 2025

AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT DATED DECEMBER 8, 2025 BY AND BETWEEN APIMEDS PHARMACEUTICALS US, INC. AND THE INVESTORS PARTY THERETO

XBRL SCHEMA FILE

XBRL LABEL FILE

XBRL PRESENTATION FILE

IDEA: XBRL DOCUMENT

IDEA: XBRL DOCUMENT

IDEA: XBRL DOCUMENT

IDEA: XBRL DOCUMENT

IDEA: XBRL DOCUMENT

IDEA: XBRL DOCUMENT

IDEA: XBRL DOCUMENT